390 related articles for article (PubMed ID: 22560210)
1. Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.
Jornayvaz FR; Shulman GI
Cell Metab; 2012 May; 15(5):574-84. PubMed ID: 22560210
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.
Birkenfeld AL; Shulman GI
Hepatology; 2014 Feb; 59(2):713-23. PubMed ID: 23929732
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans.
Ter Horst KW; Gilijamse PW; Versteeg RI; Ackermans MT; Nederveen AJ; la Fleur SE; Romijn JA; Nieuwdorp M; Zhang D; Samuel VT; Vatner DF; Petersen KF; Shulman GI; Serlie MJ
Cell Rep; 2017 Jun; 19(10):1997-2004. PubMed ID: 28591572
[TBL] [Abstract][Full Text] [Related]
4. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.
Perry RJ; Samuel VT; Petersen KF; Shulman GI
Nature; 2014 Jun; 510(7503):84-91. PubMed ID: 24899308
[TBL] [Abstract][Full Text] [Related]
5. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
Masuda S; Fujishima Y; Maeda N; Tsugawa-Shimizu Y; Nakamura Y; Tanaka Y; Obata Y; Fukuda S; Nagao H; Kita S; Nishizawa H; Shimomura I
Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E239-E250. PubMed ID: 30457913
[TBL] [Abstract][Full Text] [Related]
6. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.
Kumashiro N; Erion DM; Zhang D; Kahn M; Beddow SA; Chu X; Still CD; Gerhard GS; Han X; Dziura J; Petersen KF; Samuel VT; Shulman GI
Proc Natl Acad Sci U S A; 2011 Sep; 108(39):16381-5. PubMed ID: 21930939
[TBL] [Abstract][Full Text] [Related]
7. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2.
Jornayvaz FR; Birkenfeld AL; Jurczak MJ; Kanda S; Guigni BA; Jiang DC; Zhang D; Lee HY; Samuel VT; Shulman GI
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5748-52. PubMed ID: 21436037
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis by dietary-conjugated linoleic acid is accompanied by accumulation of diacylglycerol and increased membrane-associated protein kinase C ε in mice.
Stout MB; Liu LF; Belury MA
Mol Nutr Food Res; 2011 Jul; 55(7):1010-7. PubMed ID: 21480517
[TBL] [Abstract][Full Text] [Related]
9. Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance.
Petersen MC; Madiraju AK; Gassaway BM; Marcel M; Nasiri AR; Butrico G; Marcucci MJ; Zhang D; Abulizi A; Zhang XM; Philbrick W; Hubbard SR; Jurczak MJ; Samuel VT; Rinehart J; Shulman GI
J Clin Invest; 2016 Nov; 126(11):4361-4371. PubMed ID: 27760050
[TBL] [Abstract][Full Text] [Related]
10. A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance.
Lyu K; Zhang Y; Zhang D; Kahn M; Ter Horst KW; Rodrigues MRS; Gaspar RC; Hirabara SM; Luukkonen PK; Lee S; Bhanot S; Rinehart J; Blume N; Rasch MG; Serlie MJ; Bogan JS; Cline GW; Samuel VT; Shulman GI
Cell Metab; 2020 Oct; 32(4):654-664.e5. PubMed ID: 32882164
[TBL] [Abstract][Full Text] [Related]
11. Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?
Finck BN; Hall AM
Biomed Res Int; 2015; 2015():104132. PubMed ID: 26273583
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver.
Jelenik T; Kaul K; Séquaris G; Flögel U; Phielix E; Kotzka J; Knebel B; Fahlbusch P; Hörbelt T; Lehr S; Reinbeck AL; Müller-Wieland D; Esposito I; Shulman GI; Szendroedi J; Roden M
Diabetes; 2017 Aug; 66(8):2241-2253. PubMed ID: 28490610
[TBL] [Abstract][Full Text] [Related]
13. Caloric restriction and intermittent fasting alter hepatic lipid droplet proteome and diacylglycerol species and prevent diabetes in NZO mice.
Baumeier C; Kaiser D; Heeren J; Scheja L; John C; Weise C; Eravci M; Lagerpusch M; Schulze G; Joost HG; Schwenk RW; Schürmann A
Biochim Biophys Acta; 2015 May; 1851(5):566-76. PubMed ID: 25645620
[TBL] [Abstract][Full Text] [Related]
14. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance.
Cantley JL; Yoshimura T; Camporez JP; Zhang D; Jornayvaz FR; Kumashiro N; Guebre-Egziabher F; Jurczak MJ; Kahn M; Guigni BA; Serr J; Hankin J; Murphy RC; Cline GW; Bhanot S; Manchem VP; Brown JM; Samuel VT; Shulman GI
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1869-74. PubMed ID: 23302688
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance.
Zhang D; Liu ZX; Choi CS; Tian L; Kibbey R; Dong J; Cline GW; Wood PA; Shulman GI
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17075-80. PubMed ID: 17940018
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a potent allosteric activator of DGKQ that ameliorates obesity-induced insulin resistance via the sn-1,2-DAG-PKCε signaling axis.
Zheng ZG; Xu YY; Liu WP; Zhang Y; Zhang C; Liu HL; Zhang XY; Liu RZ; Zhang YP; Shi MY; Yang H; Li P
Cell Metab; 2023 Jan; 35(1):101-117.e11. PubMed ID: 36525963
[TBL] [Abstract][Full Text] [Related]
17. Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolism.
Chalhoub G; Jamnik A; Pajed L; Kolleritsch S; Hois V; Bagaric A; Prem D; Tilp A; Kolb D; Wolinski H; Taschler U; Züllig T; Rechberger GN; Fuchs C; Trauner M; Schoiswohl G; Haemmerle G
Mol Metab; 2023 Jun; 72():101725. PubMed ID: 37059417
[TBL] [Abstract][Full Text] [Related]
18. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
[TBL] [Abstract][Full Text] [Related]
19. Lipid-induced insulin resistance: unravelling the mechanism.
Samuel VT; Petersen KF; Shulman GI
Lancet; 2010 Jun; 375(9733):2267-77. PubMed ID: 20609972
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.
Samuel VT; Liu ZX; Wang A; Beddow SA; Geisler JG; Kahn M; Zhang XM; Monia BP; Bhanot S; Shulman GI
J Clin Invest; 2007 Mar; 117(3):739-45. PubMed ID: 17318260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
